Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • WCRC contractor transition webinar held with The Centers for Medicare and Medicaid Services

    by
    • Optum Workers' Comp
    | Mar 08, 2018
    Tag Icon
    Webinar, CMS, MSA
    The Centers for Medicare and Medicaid Services (CMS) held a webinar, March 7, 2018, to introduce Capitol Bridge LLC, our new WCRC contractor and review the transition plan.


  • FDA approves Apadaz™ - new short-acting opioid analgesic for acute pain

    by
    • Optum Workers' Comp
    | Mar 01, 2018
    Tag Icon
    Opioids, FDA
    KemPharm, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Apadaz (benzhydrocodone and acetaminophen), an immediate-release (short-acting) opioid analgesic combination product. Apadaz is intended for the short-term (no more than 14 days) management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.


  • Arizona Joins States Enacting Opioid Prescribing Restrictions

    by
    • Optum Workers' Comp
    | Feb 22, 2018
    Tag Icon
    Opioids
    Arizona’s Governor recently signed into law Senate Bill 1001 which, among other changes, establishes several new requirements for prescribing and dispensing opioids. Most notably, Arizona has gone the route of several other states over the last couple of years by enacting days’ supply and morphine milligram equivalent (MME) limits on prescriptions for these medications.


  • Purdue no longer promoting OxyContin® to doctors

    by
    • Optum Workers' Comp
    | Feb 13, 2018
    Tag Icon
    Opioids
    Purdue Pharma LP announced it will no longer actively promote OxyContin® to doctors. Following its launch in 1996, Purdue marketed the pain medication to doctors to prescribe for patients with pain. In workers’ compensation, OxyContin has been one of the most widely prescribed and highest ranked long-acting opioid analgesic in terms of medication spend in the past decade.